Shares and Stockholders' Equity

6 Months Ended

Jun. 30, 2023

Shares and Stockholders' Equity [Abstract]

15. Shares and Stockholders’ Equity

Preferred Shares

Preferred stock authorized, issued and outstanding (number of shares) was as follows:


	As of June 30, 2023			As of December 31, 2022
	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C	20,000	20,000	20,000	20,000	20,000	20,000
9.000% Non-Cumulative Preferred Stock, Series D	20,000	20,000	20,000	20,000	20,000	20,000
Not designated	9,960,000	-	-	9,960,000	-	-
Total preferred shares	10,000,000	40,000	40,000	10,000,000	40,000	40,000

The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:


		For the Three Months Ended June 30,
		2023				2022
		Dividend		Aggregate		Dividend		Aggregate
Series		Per Share		Dividend		Per Share		Dividend
Series C	$	-	$	-	$	-	$	-
Series D		562.50		11		-		-
Total	$	562.50	$	11	$	-	$	-

		For the Six Months Ended June 30,
		2023				2022
		Dividend		Aggregate		Dividend		Aggregate
Series		Per Share		Dividend		Per Share		Dividend
Series C	$	635.94	$	13	$	-	$	-
Series D		1,181.25		23		-		-
Total	$	1,817.19	$	36	$	-	$	-

Common Shares

The changes in our common stock (number of shares) were as follows:


	For the Three			For the Six
	Months Ended			Months Ended
	June 30,			June 30,
	2023	2022		2023	2022
Common Stock
Balance as of beginning-of-period	169,537,759	171,890,974		169,220,511	177,193,515
Stock compensation/issued for benefit plans	93,121	161,566		410,369	676,421
Retirement/cancellation of shares	-	(1,828,424	)	-	(7,645,820	)
Balance as of end-of-period	169,630,880	170,224,116		169,630,880	170,224,116

Common Stock as of End-of-Period
Basic basis	169,630,880	170,224,116		169,630,880	170,224,116
Diluted basis	170,610,356	171,556,357		170,610,356	171,556,357

Our common stock is without par value.

Average Common Shares

A reconciliation of the denominator (number of shares) in the calculations of basic and diluted earnings (loss) per common share was as follows:



	For the Three				For the Six
	Months Ended				Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Weighted-average shares, as used in basic calculation	169,581,636		171,130,192		169,470,359		172,633,482
Shares to cover non-vested stock	326,632		895,347		447,379		1,127,609
Average stock options outstanding during the period	5,707		1,031,878		16,065		1,664,374
Assumed acquisition of shares with assumed
proceeds and benefits from exercising stock
options (at average market price for the period)	(5,469	)	(829,921	)	(13,335	)	(1,327,773	)
Shares repurchasable from measured but
unrecognized stock option expense	-		(12,772	)	-		(42,013	)
Average deferred compensation shares	589,001		492,269		571,484		506,740
Weighted-average shares, as used in diluted calculation ⁽¹⁾	170,497,507		172,706,993		170,491,952		174,562,419

⁽¹⁾Due to reporting a net loss for the six months ended June 30, 2023, basic shares were used in the diluted earnings per share calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our earnings per share, such options will be shown in the table above.

The income used in the calculation of our diluted earnings per share is our net income (loss), reduced by preferred stock dividends. This amount is presented on our Consolidated Statements of Income (Loss).

We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted earnings per share calculation. The mark-to-market adjustment of these deferred units excluded from our diluted earnings per share calculation was $(2) million and $7 million for the three months ended June 30, 2023 and 2022, respectively, and $2 million and $7 million for the six months ended June 30, 2023 and 2022, respectively.

AOCI

The following summarizes the components and changes in AOCI (in millions):



	For the Six
	Months Ended
	June 30,
	2023			2022
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain Other
Investments
Balance as of beginning-of-year	$	(8,916	)	$	9,616
Unrealized holding gains (losses) arising during the period		803			(19,853	)
Change in foreign currency exchange rate adjustment		120			(371	)
Change in future contract benefits and policyholder account balances		(82	)		1,750
Income tax benefit (expense)		(199	)		3,943
Less:
Reclassification adjustment for gains (losses) included in net income (loss)		(707	)		(4	)
Income tax benefit (expense)		148			1
Balance as of end-of-period	$	(7,715	)	$	(4,912	)
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	388		$	(85	)
Unrealized holding gains (losses) arising during the period		230			126
Change in foreign currency exchange rate adjustment		(110	)		373
Income tax benefit (expense)		(26	)		(104	)
Less:
Reclassification adjustment for gains (losses) included in net income (loss)		43			25
Income tax benefit (expense)		(9	)		(5	)
Balance as of end-of-period	$	448		$	290
Market Risk Benefit Non-Performance Risk Gain (Loss)
Balance as of beginning-of-year	$	1,741		$	1,951
Adjustment arising during the period		129			476
Income tax benefit (expense)		(28	)		(102	)
Balance as of end-of-period	$	1,842		$	2,325
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Balance as of beginning-of-year	$	747		$	(1,265	)
Adjustment arising during the period		(116	)		1,933
Income tax benefit (expense)		26			(412	)
Balance as of end-of-period	$	657		$	256
Foreign Currency Translation Adjustment
Balance as of beginning-of-year	$	(34	)	$	(14	)
Foreign currency translation adjustment arising during the period		8			(18	)
Income tax benefit (expense)		-			(1	)
Balance as of end-of-period	$	(26	)	$	(33	)
Funded Status of Employee Benefit Plans
Balance as of beginning-of-year	$	(278	)	$	(219	)
Adjustment arising during the period		(32	)		13
Balance as of end-of-period	$	(310	)	$	(206	)

‎

The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):



	For the Six
	Months Ended
	June 30,
	2023			2022
Unrealized Gain (Loss) on Fixed Maturity AFS
Securities and Certain Other Investments
Reclassification	$	(707	)	$	(4	)	Realized gain (loss)
Reclassification before income
tax benefit (expense)		(707	)		(4	)	Income (loss) before taxes
Income tax benefit (expense)		148			1		Federal income tax expense (benefit)
Reclassification, net of income tax	$	(559	)	$	(3	)	Net income (loss)

Unrealized Gain (Loss) on Derivative Instruments
Interest rate contracts	$	-		$	1		Net investment income
Interest rate contracts		13			(10	)	Interest and debt expense
Foreign currency contracts		27			30		Net investment income
Foreign currency contracts		3			4		Realized gain (loss)
Reclassifications before income
tax benefit (expense)		43			25		Income (loss) before taxes
Income tax benefit (expense)		(9	)		(5	)	Federal income tax expense (benefit)
Reclassifications, net of income tax	$	34		$	20		Net income (loss)